OMED

OncoMed Pharmaceuticals, Inc.
OMED

Overview Fund Activity
Delisted

OMED was delisted on the 22nd of April, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in OncoMed Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
–
Holders Change
-41
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
41
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
Primecap Management
Primecap Management
California
$0
2
BI
BVF Inc
California
$0
3
Renaissance Technologies
Renaissance Technologies
New York
$0
4
PA
Perceptive Advisors
New York
$0
5
CS
Candriam SCA
Luxembourg
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
– -$21K -20,310 Closed
LWAC
27
Laurel Wealth Advisors (California)
California
– -$17K -15,900 Closed
HCM
28
Hodges Capital Management
Texas
– -$16K -15,592 Closed
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
– -$16K -14,993 Closed
Baird Financial Group
30
Baird Financial Group
Wisconsin
– -$12K -12,000 Closed
Two Sigma Advisers
31
Two Sigma Advisers
New York
– -$12K -11,300 Closed
State Street
32
State Street
Massachusetts
– -$11K -10,189 Closed
Wells Fargo
33
Wells Fargo
California
– -$2K -2,270 Closed
Fidelity Investments
34
Fidelity Investments
Massachusetts
– -$1K -1,300 Closed
UBS Group
35
UBS Group
Switzerland
– -$1K -1,200 Closed
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
– -$1K -500 Closed
1
2